These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19366074)

  • 1. Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
    Crivellari D; Colleoni M; Dellapasqua S; Goldhirsch A
    Tumori; 2009; 95(1):130; author reply 131. PubMed ID: 19366074
    [No Abstract]   [Full Text] [Related]  

  • 2. Metronomic chemotherapy in elderly patients: do risks exceed benefits in some patients?
    Arnoldi E; Dieli M; Mangia M; Labianca R
    Tumori; 2007; 93(6):647. PubMed ID: 18338509
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer: single agents chemotherapy.
    Monfardini S; Beda M; Fratino L
    Tumori; 2002; 88(1 Suppl 1):S55-6. PubMed ID: 11989925
    [No Abstract]   [Full Text] [Related]  

  • 4. Metronomic chemotherapy for advanced breast cancer patients.
    Cazzaniga ME; Dionisio MR; Riva F
    Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
    Wildiers H; Tryfonidis K; Dal Lago L; Vuylsteke P; Curigliano G; Waters S; Brouwers B; Altintas S; Touati N; Cardoso F; Brain E
    Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
    Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
    Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
    Leo S; Arnoldi E; Repetto L; Coccorullo Z; Cinieri S; Fedele P; Cazzaniga M; Lorusso V; Latorre A; Campanella G; Ciccarese M; Accettura C; Pisconti S; Rinaldi A; Brunetti C; Raffaele M; Coltelli L; Spazzapan S; Fratino L; Petrucelli L; Biganzoli L
    Oncologist; 2019 Jun; 24(6):e232-e240. PubMed ID: 30413667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cardiac risk before anthracycline administration: what are the real benefits?
    Ewer MS; Yang M; Buzdar AU
    Clin Breast Cancer; 2012 Feb; 12(1):1-3. PubMed ID: 22130035
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical overview of metronomic chemotherapy in breast cancer.
    Munzone E; Colleoni M
    Nat Rev Clin Oncol; 2015 Nov; 12(11):631-44. PubMed ID: 26241939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic chemotherapy in metastatic colorectal cancer.
    Woo IS; Jung YH
    Cancer Lett; 2017 Aug; 400():319-324. PubMed ID: 28274890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab and cardiotoxicity: weighing the risks.
    Wong SF
    Am J Health Syst Pharm; 2006 Mar; 63(6):525. PubMed ID: 16522888
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer.
    Cho E; Wu Q; Rubinstein L; Linden H; Gralow J; Specht J; Gadi V; Ellis G
    Breast J; 2018 Jul; 24(4):610-614. PubMed ID: 29532546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.
    Decoster L; Fontaine C; Vanacker L; Schallier D; De Grève J
    Breast J; 2018 Jul; 24(4):695-697. PubMed ID: 29286203
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new therapeutic strategy in breast cancer: metronomic chemotherapy].
    Khosravi Shahi P; Pérez Manga G
    An Med Interna; 2007 Jun; 24(6):261-2. PubMed ID: 17907894
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.
    Zhao X; Xu X; Guo L; Ragaz J; Guo H; Wu J; Shao Z; Zhu J; Guo X; Chen J; Zhu B; Wang Z; Hu X
    Breast Cancer Res Treat; 2010 Dec; 124(3):733-43. PubMed ID: 20882405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed initiation of adjuvant chemotherapy in older women with breast cancer.
    Smith-Graziani D; Lei X; Giordano SH; Zhao H; Karuturi M; Chavez-MacGregor M
    Cancer Med; 2020 Oct; 9(19):6961-6971. PubMed ID: 32767723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy.
    Munoz R; Shaked Y; Bertolini F; Emmenegger U; Man S; Kerbel RS
    Breast; 2005 Dec; 14(6):466-79. PubMed ID: 16199161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronomic therapy and breast cancer: a systematic review.
    Montagna E; Cancello G; Dellapasqua S; Munzone E; Colleoni M
    Cancer Treat Rev; 2014 Sep; 40(8):942-50. PubMed ID: 24998489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer.
    de Nonneville A; Sabatier R; Gonçalves A; Extra JM; Tarpin C; Launay S; Tassy L; Viens P; Rousseau F
    J Geriatr Oncol; 2018 May; 9(3):281-283. PubMed ID: 29174186
    [No Abstract]   [Full Text] [Related]  

  • 20. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer.
    Petry V; Gagliato DM; Leal AI; Arai RJ; Longo E; Andrade F; Ricci MD; Piato JR; Barroso-Sousa R; Hoff PM; Mano MS
    Braz J Med Biol Res; 2015 May; 48(5):479-85. PubMed ID: 25760024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.